nodes	percent_of_prediction	percent_of_DWPC	metapath
Zafirlukast—ABCG2—Topotecan—ovarian cancer	0.175	0.252	CbGbCtD
Zafirlukast—ABCG2—Paclitaxel—ovarian cancer	0.0866	0.125	CbGbCtD
Zafirlukast—ABCG2—Carboplatin—ovarian cancer	0.0815	0.117	CbGbCtD
Zafirlukast—ABCG2—Docetaxel—ovarian cancer	0.0626	0.0901	CbGbCtD
Zafirlukast—ABCG2—Doxorubicin—ovarian cancer	0.0466	0.0671	CbGbCtD
Zafirlukast—CYP2C8—Paclitaxel—ovarian cancer	0.0461	0.0664	CbGbCtD
Zafirlukast—CYP2D6—Vinorelbine—ovarian cancer	0.0419	0.0602	CbGbCtD
Zafirlukast—CYP3A4—Topotecan—ovarian cancer	0.0378	0.0544	CbGbCtD
Zafirlukast—CYP2C9—Paclitaxel—ovarian cancer	0.0322	0.0463	CbGbCtD
Zafirlukast—CYP3A4—Vinorelbine—ovarian cancer	0.0266	0.0383	CbGbCtD
Zafirlukast—CYP3A4—Paclitaxel—ovarian cancer	0.0187	0.0269	CbGbCtD
Zafirlukast—CYP2D6—Doxorubicin—ovarian cancer	0.0158	0.0228	CbGbCtD
Zafirlukast—CYP3A4—Docetaxel—ovarian cancer	0.0135	0.0195	CbGbCtD
Zafirlukast—CYP3A4—Doxorubicin—ovarian cancer	0.0101	0.0145	CbGbCtD
Zafirlukast—CYSLTR2—female reproductive system—ovarian cancer	0.0064	0.158	CbGeAlD
Zafirlukast—PTGS1—oviduct—ovarian cancer	0.00314	0.0774	CbGeAlD
Zafirlukast—CYSLTR1—uterus—ovarian cancer	0.00268	0.0661	CbGeAlD
Zafirlukast—CYSLTR1—female reproductive system—ovarian cancer	0.00241	0.0594	CbGeAlD
Zafirlukast—CYSLTR1—bone marrow—ovarian cancer	0.00227	0.0561	CbGeAlD
Zafirlukast—CYSLTR1—vagina—ovarian cancer	0.00218	0.0537	CbGeAlD
Zafirlukast—Tolvaptan—ABCB1—ovarian cancer	0.0015	0.768	CrCbGaD
Zafirlukast—CYSLTR1—lymph node—ovarian cancer	0.00141	0.0347	CbGeAlD
Zafirlukast—ABCG2—myometrium—ovarian cancer	0.0012	0.0297	CbGeAlD
Zafirlukast—ABCG2—uterine cervix—ovarian cancer	0.000937	0.0231	CbGeAlD
Zafirlukast—ABCG2—decidua—ovarian cancer	0.000892	0.022	CbGeAlD
Zafirlukast—CYP2C8—endometrium—ovarian cancer	0.000871	0.0215	CbGeAlD
Zafirlukast—ABCG2—endometrium—ovarian cancer	0.000847	0.0209	CbGeAlD
Zafirlukast—PTGS1—epithelium—ovarian cancer	0.000788	0.0194	CbGeAlD
Zafirlukast—PTGS1—uterine cervix—ovarian cancer	0.000781	0.0193	CbGeAlD
Zafirlukast—ABCG2—uterus—ovarian cancer	0.000781	0.0193	CbGeAlD
Zafirlukast—CYP2C19—vagina—ovarian cancer	0.000748	0.0184	CbGeAlD
Zafirlukast—Hyperbilirubinaemia—Epirubicin—ovarian cancer	0.000745	0.00335	CcSEcCtD
Zafirlukast—Back pain—Vinorelbine—ovarian cancer	0.000745	0.00335	CcSEcCtD
Zafirlukast—Liver injury—Doxorubicin—ovarian cancer	0.000745	0.00335	CcSEcCtD
Zafirlukast—Infection—Topotecan—ovarian cancer	0.00073	0.00329	CcSEcCtD
Zafirlukast—Dyspepsia—Chlorambucil—ovarian cancer	0.000727	0.00327	CcSEcCtD
Zafirlukast—CYP2C8—female reproductive system—ovarian cancer	0.000722	0.0178	CbGeAlD
Zafirlukast—Oedema—Melphalan—ovarian cancer	0.00072	0.00324	CcSEcCtD
Zafirlukast—Thrombocytopenia—Topotecan—ovarian cancer	0.00072	0.00324	CcSEcCtD
Zafirlukast—Infection—Melphalan—ovarian cancer	0.000715	0.00322	CcSEcCtD
Zafirlukast—Ill-defined disorder—Vinorelbine—ovarian cancer	0.000715	0.00322	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Chlorambucil—ovarian cancer	0.000713	0.00321	CcSEcCtD
Zafirlukast—Fatigue—Chlorambucil—ovarian cancer	0.000712	0.0032	CcSEcCtD
Zafirlukast—PTGS1—endometrium—ovarian cancer	0.000707	0.0174	CbGeAlD
Zafirlukast—Pain—Chlorambucil—ovarian cancer	0.000706	0.00318	CcSEcCtD
Zafirlukast—Thrombocytopenia—Melphalan—ovarian cancer	0.000705	0.00317	CcSEcCtD
Zafirlukast—Angioedema—Vinorelbine—ovarian cancer	0.000704	0.00317	CcSEcCtD
Zafirlukast—Neutropenia—Paclitaxel—ovarian cancer	0.000695	0.00313	CcSEcCtD
Zafirlukast—Malaise—Vinorelbine—ovarian cancer	0.000695	0.00313	CcSEcCtD
Zafirlukast—Rectal haemorrhage—Doxorubicin—ovarian cancer	0.000694	0.00312	CcSEcCtD
Zafirlukast—Hyperbilirubinaemia—Doxorubicin—ovarian cancer	0.00069	0.0031	CcSEcCtD
Zafirlukast—Feeling abnormal—Chlorambucil—ovarian cancer	0.00068	0.00306	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Chlorambucil—ovarian cancer	0.000675	0.00304	CcSEcCtD
Zafirlukast—Liver function test abnormal—Docetaxel—ovarian cancer	0.000673	0.00303	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Topotecan—ovarian cancer	0.00067	0.00301	CcSEcCtD
Zafirlukast—ABCG2—bone marrow—ovarian cancer	0.000663	0.0163	CbGeAlD
Zafirlukast—Influenza like illness—Epirubicin—ovarian cancer	0.000658	0.00296	CcSEcCtD
Zafirlukast—Urticaria—Chlorambucil—ovarian cancer	0.000656	0.00295	CcSEcCtD
Zafirlukast—Arthralgia—Vinorelbine—ovarian cancer	0.000656	0.00295	CcSEcCtD
Zafirlukast—Myalgia—Vinorelbine—ovarian cancer	0.000656	0.00295	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Melphalan—ovarian cancer	0.000656	0.00295	CcSEcCtD
Zafirlukast—CYP2C8—vagina—ovarian cancer	0.000653	0.0161	CbGeAlD
Zafirlukast—Abdominal pain—Chlorambucil—ovarian cancer	0.000653	0.00294	CcSEcCtD
Zafirlukast—Body temperature increased—Chlorambucil—ovarian cancer	0.000653	0.00294	CcSEcCtD
Zafirlukast—PTGS1—uterus—ovarian cancer	0.000651	0.0161	CbGeAlD
Zafirlukast—Neuropathy peripheral—Paclitaxel—ovarian cancer	0.00065	0.00292	CcSEcCtD
Zafirlukast—Discomfort—Vinorelbine—ovarian cancer	0.000648	0.00292	CcSEcCtD
Zafirlukast—Dyspepsia—Topotecan—ovarian cancer	0.000647	0.00291	CcSEcCtD
Zafirlukast—CYP2C9—female reproductive system—ovarian cancer	0.000641	0.0158	CbGeAlD
Zafirlukast—ABCG2—female gonad—ovarian cancer	0.000639	0.0157	CbGeAlD
Zafirlukast—Neuropathy—Epirubicin—ovarian cancer	0.000636	0.00286	CcSEcCtD
Zafirlukast—ABCG2—vagina—ovarian cancer	0.000635	0.0157	CbGeAlD
Zafirlukast—Gastrointestinal disorder—Topotecan—ovarian cancer	0.000635	0.00286	CcSEcCtD
Zafirlukast—Fatigue—Topotecan—ovarian cancer	0.000634	0.00285	CcSEcCtD
Zafirlukast—Dyspepsia—Melphalan—ovarian cancer	0.000634	0.00285	CcSEcCtD
Zafirlukast—Pain—Topotecan—ovarian cancer	0.000629	0.00283	CcSEcCtD
Zafirlukast—Infection—Vinorelbine—ovarian cancer	0.000625	0.00281	CcSEcCtD
Zafirlukast—Sinusitis—Paclitaxel—ovarian cancer	0.000622	0.0028	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Melphalan—ovarian cancer	0.000621	0.0028	CcSEcCtD
Zafirlukast—Fatigue—Melphalan—ovarian cancer	0.00062	0.00279	CcSEcCtD
Zafirlukast—Thrombocytopenia—Vinorelbine—ovarian cancer	0.000616	0.00277	CcSEcCtD
Zafirlukast—Pain—Melphalan—ovarian cancer	0.000615	0.00277	CcSEcCtD
Zafirlukast—Influenza like illness—Doxorubicin—ovarian cancer	0.000609	0.00274	CcSEcCtD
Zafirlukast—Hypersensitivity—Chlorambucil—ovarian cancer	0.000608	0.00274	CcSEcCtD
Zafirlukast—CYP2E1—female reproductive system—ovarian cancer	0.000608	0.015	CbGeAlD
Zafirlukast—Feeling abnormal—Topotecan—ovarian cancer	0.000606	0.00273	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Topotecan—ovarian cancer	0.000601	0.0027	CcSEcCtD
Zafirlukast—Haemoglobin—Paclitaxel—ovarian cancer	0.000598	0.00269	CcSEcCtD
Zafirlukast—Haemorrhage—Paclitaxel—ovarian cancer	0.000595	0.00268	CcSEcCtD
Zafirlukast—Asthenia—Chlorambucil—ovarian cancer	0.000592	0.00267	CcSEcCtD
Zafirlukast—Hypoaesthesia—Paclitaxel—ovarian cancer	0.000592	0.00267	CcSEcCtD
Zafirlukast—Neutropenia—Docetaxel—ovarian cancer	0.000589	0.00265	CcSEcCtD
Zafirlukast—Neuropathy—Doxorubicin—ovarian cancer	0.000589	0.00265	CcSEcCtD
Zafirlukast—PTGS1—female reproductive system—ovarian cancer	0.000585	0.0144	CbGeAlD
Zafirlukast—Pruritus—Chlorambucil—ovarian cancer	0.000584	0.00263	CcSEcCtD
Zafirlukast—Urticaria—Topotecan—ovarian cancer	0.000584	0.00263	CcSEcCtD
Zafirlukast—CYP2C8—testis—ovarian cancer	0.000582	0.0144	CbGeAlD
Zafirlukast—Abdominal pain—Topotecan—ovarian cancer	0.000581	0.00261	CcSEcCtD
Zafirlukast—Body temperature increased—Topotecan—ovarian cancer	0.000581	0.00261	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Vinorelbine—ovarian cancer	0.000573	0.00258	CcSEcCtD
Zafirlukast—Urticaria—Melphalan—ovarian cancer	0.000572	0.00257	CcSEcCtD
Zafirlukast—ABCG2—testis—ovarian cancer	0.000566	0.014	CbGeAlD
Zafirlukast—Diarrhoea—Chlorambucil—ovarian cancer	0.000565	0.00254	CcSEcCtD
Zafirlukast—Hepatic function abnormal—Epirubicin—ovarian cancer	0.000563	0.00253	CcSEcCtD
Zafirlukast—Neuropathy peripheral—Docetaxel—ovarian cancer	0.000551	0.00248	CcSEcCtD
Zafirlukast—Jaundice—Docetaxel—ovarian cancer	0.000548	0.00247	CcSEcCtD
Zafirlukast—Hepatic failure—Epirubicin—ovarian cancer	0.000547	0.00246	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Vinorelbine—ovarian cancer	0.000543	0.00244	CcSEcCtD
Zafirlukast—Fatigue—Vinorelbine—ovarian cancer	0.000542	0.00244	CcSEcCtD
Zafirlukast—Hypersensitivity—Topotecan—ovarian cancer	0.000542	0.00244	CcSEcCtD
Zafirlukast—Pain—Vinorelbine—ovarian cancer	0.000538	0.00242	CcSEcCtD
Zafirlukast—PTGS1—female gonad—ovarian cancer	0.000533	0.0131	CbGeAlD
Zafirlukast—Hypersensitivity—Melphalan—ovarian cancer	0.00053	0.00239	CcSEcCtD
Zafirlukast—PTGS1—vagina—ovarian cancer	0.000529	0.0131	CbGeAlD
Zafirlukast—Asthenia—Topotecan—ovarian cancer	0.000527	0.00237	CcSEcCtD
Zafirlukast—Vomiting—Chlorambucil—ovarian cancer	0.000525	0.00236	CcSEcCtD
Zafirlukast—Agranulocytosis—Docetaxel—ovarian cancer	0.000524	0.00236	CcSEcCtD
Zafirlukast—Hepatic function abnormal—Doxorubicin—ovarian cancer	0.000521	0.00234	CcSEcCtD
Zafirlukast—Pruritus—Topotecan—ovarian cancer	0.00052	0.00234	CcSEcCtD
Zafirlukast—Feeling abnormal—Vinorelbine—ovarian cancer	0.000518	0.00233	CcSEcCtD
Zafirlukast—Asthenia—Melphalan—ovarian cancer	0.000516	0.00232	CcSEcCtD
Zafirlukast—Dermatitis bullous—Epirubicin—ovarian cancer	0.000515	0.00232	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Vinorelbine—ovarian cancer	0.000514	0.00231	CcSEcCtD
Zafirlukast—Pruritus—Melphalan—ovarian cancer	0.000509	0.00229	CcSEcCtD
Zafirlukast—Haemoglobin—Docetaxel—ovarian cancer	0.000507	0.00228	CcSEcCtD
Zafirlukast—Hepatic failure—Doxorubicin—ovarian cancer	0.000506	0.00228	CcSEcCtD
Zafirlukast—Hepatitis—Docetaxel—ovarian cancer	0.000505	0.00227	CcSEcCtD
Zafirlukast—Haemorrhage—Docetaxel—ovarian cancer	0.000505	0.00227	CcSEcCtD
Zafirlukast—Diarrhoea—Topotecan—ovarian cancer	0.000503	0.00226	CcSEcCtD
Zafirlukast—Hypoaesthesia—Docetaxel—ovarian cancer	0.000502	0.00226	CcSEcCtD
Zafirlukast—Back pain—Paclitaxel—ovarian cancer	0.000501	0.00226	CcSEcCtD
Zafirlukast—Urticaria—Vinorelbine—ovarian cancer	0.000499	0.00225	CcSEcCtD
Zafirlukast—Abdominal pain—Vinorelbine—ovarian cancer	0.000497	0.00224	CcSEcCtD
Zafirlukast—Body temperature increased—Vinorelbine—ovarian cancer	0.000497	0.00224	CcSEcCtD
Zafirlukast—Diarrhoea—Melphalan—ovarian cancer	0.000492	0.00222	CcSEcCtD
Zafirlukast—Nausea—Chlorambucil—ovarian cancer	0.00049	0.00221	CcSEcCtD
Zafirlukast—CYP2E1—testis—ovarian cancer	0.00049	0.0121	CbGeAlD
Zafirlukast—CYP3A4—female reproductive system—ovarian cancer	0.000489	0.0121	CbGeAlD
Zafirlukast—Dizziness—Topotecan—ovarian cancer	0.000486	0.00219	CcSEcCtD
Zafirlukast—CYP2D6—female reproductive system—ovarian cancer	0.000481	0.0119	CbGeAlD
Zafirlukast—Ill-defined disorder—Paclitaxel—ovarian cancer	0.000481	0.00216	CcSEcCtD
Zafirlukast—Dermatitis bullous—Doxorubicin—ovarian cancer	0.000476	0.00214	CcSEcCtD
Zafirlukast—Angioedema—Paclitaxel—ovarian cancer	0.000473	0.00213	CcSEcCtD
Zafirlukast—PTGS1—testis—ovarian cancer	0.000472	0.0116	CbGeAlD
Zafirlukast—Vomiting—Topotecan—ovarian cancer	0.000467	0.0021	CcSEcCtD
Zafirlukast—Malaise—Paclitaxel—ovarian cancer	0.000467	0.0021	CcSEcCtD
Zafirlukast—Rash—Topotecan—ovarian cancer	0.000463	0.00209	CcSEcCtD
Zafirlukast—Hypersensitivity—Vinorelbine—ovarian cancer	0.000463	0.00208	CcSEcCtD
Zafirlukast—Dermatitis—Topotecan—ovarian cancer	0.000463	0.00208	CcSEcCtD
Zafirlukast—Headache—Topotecan—ovarian cancer	0.00046	0.00207	CcSEcCtD
Zafirlukast—Vomiting—Melphalan—ovarian cancer	0.000458	0.00206	CcSEcCtD
Zafirlukast—Liver function test abnormal—Epirubicin—ovarian cancer	0.000454	0.00204	CcSEcCtD
Zafirlukast—Rash—Melphalan—ovarian cancer	0.000454	0.00204	CcSEcCtD
Zafirlukast—Dermatitis—Melphalan—ovarian cancer	0.000453	0.00204	CcSEcCtD
Zafirlukast—Glyburide—ABCB1—ovarian cancer	0.000453	0.232	CrCbGaD
Zafirlukast—Asthenia—Vinorelbine—ovarian cancer	0.000451	0.00203	CcSEcCtD
Zafirlukast—Pruritus—Vinorelbine—ovarian cancer	0.000445	0.002	CcSEcCtD
Zafirlukast—Myalgia—Paclitaxel—ovarian cancer	0.000441	0.00199	CcSEcCtD
Zafirlukast—Arthralgia—Paclitaxel—ovarian cancer	0.000441	0.00199	CcSEcCtD
Zafirlukast—CYP2D6—female gonad—ovarian cancer	0.000438	0.0108	CbGeAlD
Zafirlukast—Nausea—Topotecan—ovarian cancer	0.000437	0.00196	CcSEcCtD
Zafirlukast—Discomfort—Paclitaxel—ovarian cancer	0.000436	0.00196	CcSEcCtD
Zafirlukast—Diarrhoea—Vinorelbine—ovarian cancer	0.00043	0.00194	CcSEcCtD
Zafirlukast—Nausea—Melphalan—ovarian cancer	0.000427	0.00192	CcSEcCtD
Zafirlukast—Back pain—Docetaxel—ovarian cancer	0.000425	0.00191	CcSEcCtD
Zafirlukast—Oedema—Paclitaxel—ovarian cancer	0.000423	0.0019	CcSEcCtD
Zafirlukast—Eosinophilia—Epirubicin—ovarian cancer	0.000421	0.00189	CcSEcCtD
Zafirlukast—Liver function test abnormal—Doxorubicin—ovarian cancer	0.00042	0.00189	CcSEcCtD
Zafirlukast—Infection—Paclitaxel—ovarian cancer	0.00042	0.00189	CcSEcCtD
Zafirlukast—Dizziness—Vinorelbine—ovarian cancer	0.000416	0.00187	CcSEcCtD
Zafirlukast—Thrombocytopenia—Paclitaxel—ovarian cancer	0.000414	0.00186	CcSEcCtD
Zafirlukast—ABCG2—lymph node—ovarian cancer	0.000411	0.0101	CbGeAlD
Zafirlukast—Vomiting—Vinorelbine—ovarian cancer	0.0004	0.0018	CcSEcCtD
Zafirlukast—Neutropenia—Epirubicin—ovarian cancer	0.000398	0.00179	CcSEcCtD
Zafirlukast—Rash—Vinorelbine—ovarian cancer	0.000396	0.00178	CcSEcCtD
Zafirlukast—Dermatitis—Vinorelbine—ovarian cancer	0.000396	0.00178	CcSEcCtD
Zafirlukast—Headache—Vinorelbine—ovarian cancer	0.000394	0.00177	CcSEcCtD
Zafirlukast—Eosinophilia—Doxorubicin—ovarian cancer	0.00039	0.00175	CcSEcCtD
Zafirlukast—CYP2D6—testis—ovarian cancer	0.000388	0.00958	CbGeAlD
Zafirlukast—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.000385	0.00173	CcSEcCtD
Zafirlukast—Insomnia—Paclitaxel—ovarian cancer	0.000383	0.00172	CcSEcCtD
Zafirlukast—Myalgia—Docetaxel—ovarian cancer	0.000374	0.00168	CcSEcCtD
Zafirlukast—Arthralgia—Docetaxel—ovarian cancer	0.000374	0.00168	CcSEcCtD
Zafirlukast—Nausea—Vinorelbine—ovarian cancer	0.000373	0.00168	CcSEcCtD
Zafirlukast—Dyspepsia—Paclitaxel—ovarian cancer	0.000372	0.00168	CcSEcCtD
Zafirlukast—Neuropathy peripheral—Epirubicin—ovarian cancer	0.000372	0.00167	CcSEcCtD
Zafirlukast—Jaundice—Epirubicin—ovarian cancer	0.00037	0.00166	CcSEcCtD
Zafirlukast—Neutropenia—Doxorubicin—ovarian cancer	0.000368	0.00166	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000365	0.00164	CcSEcCtD
Zafirlukast—Fatigue—Paclitaxel—ovarian cancer	0.000365	0.00164	CcSEcCtD
Zafirlukast—Pain—Paclitaxel—ovarian cancer	0.000362	0.00163	CcSEcCtD
Zafirlukast—Oedema—Docetaxel—ovarian cancer	0.000358	0.00161	CcSEcCtD
Zafirlukast—Infection—Docetaxel—ovarian cancer	0.000356	0.0016	CcSEcCtD
Zafirlukast—Sinusitis—Epirubicin—ovarian cancer	0.000356	0.0016	CcSEcCtD
Zafirlukast—Agranulocytosis—Epirubicin—ovarian cancer	0.000354	0.00159	CcSEcCtD
Zafirlukast—Thrombocytopenia—Docetaxel—ovarian cancer	0.000351	0.00158	CcSEcCtD
Zafirlukast—Feeling abnormal—Paclitaxel—ovarian cancer	0.000348	0.00157	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000346	0.00156	CcSEcCtD
Zafirlukast—Neuropathy peripheral—Doxorubicin—ovarian cancer	0.000344	0.00155	CcSEcCtD
Zafirlukast—PTGS1—lymph node—ovarian cancer	0.000342	0.00844	CbGeAlD
Zafirlukast—Haemoglobin—Epirubicin—ovarian cancer	0.000342	0.00154	CcSEcCtD
Zafirlukast—Jaundice—Doxorubicin—ovarian cancer	0.000342	0.00154	CcSEcCtD
Zafirlukast—Haemorrhage—Epirubicin—ovarian cancer	0.00034	0.00153	CcSEcCtD
Zafirlukast—Hepatitis—Epirubicin—ovarian cancer	0.00034	0.00153	CcSEcCtD
Zafirlukast—Hypoaesthesia—Epirubicin—ovarian cancer	0.000339	0.00152	CcSEcCtD
Zafirlukast—Urticaria—Paclitaxel—ovarian cancer	0.000336	0.00151	CcSEcCtD
Zafirlukast—Body temperature increased—Paclitaxel—ovarian cancer	0.000334	0.0015	CcSEcCtD
Zafirlukast—Abdominal pain—Paclitaxel—ovarian cancer	0.000334	0.0015	CcSEcCtD
Zafirlukast—Sinusitis—Doxorubicin—ovarian cancer	0.000329	0.00148	CcSEcCtD
Zafirlukast—Agranulocytosis—Doxorubicin—ovarian cancer	0.000327	0.00147	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000327	0.00147	CcSEcCtD
Zafirlukast—Insomnia—Docetaxel—ovarian cancer	0.000324	0.00146	CcSEcCtD
Zafirlukast—Haemoglobin—Doxorubicin—ovarian cancer	0.000316	0.00142	CcSEcCtD
Zafirlukast—Dyspepsia—Docetaxel—ovarian cancer	0.000316	0.00142	CcSEcCtD
Zafirlukast—Haemorrhage—Doxorubicin—ovarian cancer	0.000315	0.00142	CcSEcCtD
Zafirlukast—Hepatitis—Doxorubicin—ovarian cancer	0.000315	0.00142	CcSEcCtD
Zafirlukast—Hypoaesthesia—Doxorubicin—ovarian cancer	0.000313	0.00141	CcSEcCtD
Zafirlukast—Hypersensitivity—Paclitaxel—ovarian cancer	0.000312	0.0014	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000309	0.00139	CcSEcCtD
Zafirlukast—Fatigue—Docetaxel—ovarian cancer	0.000309	0.00139	CcSEcCtD
Zafirlukast—Pain—Docetaxel—ovarian cancer	0.000307	0.00138	CcSEcCtD
Zafirlukast—Asthenia—Paclitaxel—ovarian cancer	0.000303	0.00137	CcSEcCtD
Zafirlukast—Pruritus—Paclitaxel—ovarian cancer	0.000299	0.00135	CcSEcCtD
Zafirlukast—Feeling abnormal—Docetaxel—ovarian cancer	0.000295	0.00133	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000293	0.00132	CcSEcCtD
Zafirlukast—Diarrhoea—Paclitaxel—ovarian cancer	0.000289	0.0013	CcSEcCtD
Zafirlukast—Back pain—Epirubicin—ovarian cancer	0.000287	0.00129	CcSEcCtD
Zafirlukast—Body temperature increased—Docetaxel—ovarian cancer	0.000283	0.00128	CcSEcCtD
Zafirlukast—Abdominal pain—Docetaxel—ovarian cancer	0.000283	0.00128	CcSEcCtD
Zafirlukast—Dizziness—Paclitaxel—ovarian cancer	0.00028	0.00126	CcSEcCtD
Zafirlukast—Ill-defined disorder—Epirubicin—ovarian cancer	0.000275	0.00124	CcSEcCtD
Zafirlukast—Vomiting—Paclitaxel—ovarian cancer	0.000269	0.00121	CcSEcCtD
Zafirlukast—Malaise—Epirubicin—ovarian cancer	0.000267	0.0012	CcSEcCtD
Zafirlukast—Rash—Paclitaxel—ovarian cancer	0.000267	0.0012	CcSEcCtD
Zafirlukast—Dermatitis—Paclitaxel—ovarian cancer	0.000266	0.0012	CcSEcCtD
Zafirlukast—Back pain—Doxorubicin—ovarian cancer	0.000265	0.00119	CcSEcCtD
Zafirlukast—Headache—Paclitaxel—ovarian cancer	0.000265	0.00119	CcSEcCtD
Zafirlukast—Hypersensitivity—Docetaxel—ovarian cancer	0.000264	0.00119	CcSEcCtD
Zafirlukast—Asthenia—Docetaxel—ovarian cancer	0.000257	0.00116	CcSEcCtD
Zafirlukast—Ill-defined disorder—Doxorubicin—ovarian cancer	0.000254	0.00114	CcSEcCtD
Zafirlukast—Pruritus—Docetaxel—ovarian cancer	0.000254	0.00114	CcSEcCtD
Zafirlukast—Myalgia—Epirubicin—ovarian cancer	0.000252	0.00113	CcSEcCtD
Zafirlukast—Arthralgia—Epirubicin—ovarian cancer	0.000252	0.00113	CcSEcCtD
Zafirlukast—Nausea—Paclitaxel—ovarian cancer	0.000251	0.00113	CcSEcCtD
Zafirlukast—Discomfort—Epirubicin—ovarian cancer	0.000249	0.00112	CcSEcCtD
Zafirlukast—Malaise—Doxorubicin—ovarian cancer	0.000247	0.00111	CcSEcCtD
Zafirlukast—Diarrhoea—Docetaxel—ovarian cancer	0.000245	0.0011	CcSEcCtD
Zafirlukast—Oedema—Epirubicin—ovarian cancer	0.000242	0.00109	CcSEcCtD
Zafirlukast—Infection—Epirubicin—ovarian cancer	0.00024	0.00108	CcSEcCtD
Zafirlukast—Dizziness—Docetaxel—ovarian cancer	0.000237	0.00107	CcSEcCtD
Zafirlukast—Thrombocytopenia—Epirubicin—ovarian cancer	0.000237	0.00107	CcSEcCtD
Zafirlukast—Myalgia—Doxorubicin—ovarian cancer	0.000233	0.00105	CcSEcCtD
Zafirlukast—Arthralgia—Doxorubicin—ovarian cancer	0.000233	0.00105	CcSEcCtD
Zafirlukast—Discomfort—Doxorubicin—ovarian cancer	0.000231	0.00104	CcSEcCtD
Zafirlukast—Vomiting—Docetaxel—ovarian cancer	0.000228	0.00103	CcSEcCtD
Zafirlukast—Rash—Docetaxel—ovarian cancer	0.000226	0.00102	CcSEcCtD
Zafirlukast—Dermatitis—Docetaxel—ovarian cancer	0.000226	0.00102	CcSEcCtD
Zafirlukast—Headache—Docetaxel—ovarian cancer	0.000225	0.00101	CcSEcCtD
Zafirlukast—Oedema—Doxorubicin—ovarian cancer	0.000224	0.00101	CcSEcCtD
Zafirlukast—Infection—Doxorubicin—ovarian cancer	0.000222	0.001	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.00022	0.000991	CcSEcCtD
Zafirlukast—Thrombocytopenia—Doxorubicin—ovarian cancer	0.000219	0.000986	CcSEcCtD
Zafirlukast—Insomnia—Epirubicin—ovarian cancer	0.000219	0.000984	CcSEcCtD
Zafirlukast—Nausea—Docetaxel—ovarian cancer	0.000213	0.000958	CcSEcCtD
Zafirlukast—Dyspepsia—Epirubicin—ovarian cancer	0.000213	0.000958	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000209	0.000939	CcSEcCtD
Zafirlukast—Fatigue—Epirubicin—ovarian cancer	0.000208	0.000938	CcSEcCtD
Zafirlukast—Pain—Epirubicin—ovarian cancer	0.000207	0.00093	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000204	0.000917	CcSEcCtD
Zafirlukast—Insomnia—Doxorubicin—ovarian cancer	0.000202	0.000911	CcSEcCtD
Zafirlukast—Feeling abnormal—Epirubicin—ovarian cancer	0.000199	0.000897	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000198	0.00089	CcSEcCtD
Zafirlukast—Dyspepsia—Doxorubicin—ovarian cancer	0.000197	0.000886	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000193	0.000869	CcSEcCtD
Zafirlukast—Fatigue—Doxorubicin—ovarian cancer	0.000193	0.000868	CcSEcCtD
Zafirlukast—Urticaria—Epirubicin—ovarian cancer	0.000192	0.000864	CcSEcCtD
Zafirlukast—Pain—Doxorubicin—ovarian cancer	0.000191	0.000861	CcSEcCtD
Zafirlukast—Abdominal pain—Epirubicin—ovarian cancer	0.000191	0.00086	CcSEcCtD
Zafirlukast—Body temperature increased—Epirubicin—ovarian cancer	0.000191	0.00086	CcSEcCtD
Zafirlukast—Feeling abnormal—Doxorubicin—ovarian cancer	0.000184	0.00083	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000183	0.000823	CcSEcCtD
Zafirlukast—Hypersensitivity—Epirubicin—ovarian cancer	0.000178	0.000802	CcSEcCtD
Zafirlukast—Urticaria—Doxorubicin—ovarian cancer	0.000178	0.0008	CcSEcCtD
Zafirlukast—Abdominal pain—Doxorubicin—ovarian cancer	0.000177	0.000796	CcSEcCtD
Zafirlukast—Body temperature increased—Doxorubicin—ovarian cancer	0.000177	0.000796	CcSEcCtD
Zafirlukast—Asthenia—Epirubicin—ovarian cancer	0.000173	0.000781	CcSEcCtD
Zafirlukast—Pruritus—Epirubicin—ovarian cancer	0.000171	0.00077	CcSEcCtD
Zafirlukast—Diarrhoea—Epirubicin—ovarian cancer	0.000165	0.000744	CcSEcCtD
Zafirlukast—Hypersensitivity—Doxorubicin—ovarian cancer	0.000165	0.000742	CcSEcCtD
Zafirlukast—Asthenia—Doxorubicin—ovarian cancer	0.000161	0.000722	CcSEcCtD
Zafirlukast—Dizziness—Epirubicin—ovarian cancer	0.00016	0.000719	CcSEcCtD
Zafirlukast—Pruritus—Doxorubicin—ovarian cancer	0.000158	0.000712	CcSEcCtD
Zafirlukast—Vomiting—Epirubicin—ovarian cancer	0.000154	0.000692	CcSEcCtD
Zafirlukast—Diarrhoea—Doxorubicin—ovarian cancer	0.000153	0.000689	CcSEcCtD
Zafirlukast—Rash—Epirubicin—ovarian cancer	0.000152	0.000686	CcSEcCtD
Zafirlukast—Dermatitis—Epirubicin—ovarian cancer	0.000152	0.000685	CcSEcCtD
Zafirlukast—Headache—Epirubicin—ovarian cancer	0.000151	0.000682	CcSEcCtD
Zafirlukast—Dizziness—Doxorubicin—ovarian cancer	0.000148	0.000666	CcSEcCtD
Zafirlukast—Nausea—Epirubicin—ovarian cancer	0.000144	0.000646	CcSEcCtD
Zafirlukast—Vomiting—Doxorubicin—ovarian cancer	0.000142	0.00064	CcSEcCtD
Zafirlukast—Rash—Doxorubicin—ovarian cancer	0.000141	0.000635	CcSEcCtD
Zafirlukast—Dermatitis—Doxorubicin—ovarian cancer	0.000141	0.000634	CcSEcCtD
Zafirlukast—Headache—Doxorubicin—ovarian cancer	0.00014	0.000631	CcSEcCtD
Zafirlukast—Nausea—Doxorubicin—ovarian cancer	0.000133	0.000598	CcSEcCtD
Zafirlukast—CYSLTR2—Signaling Pathways—IL2—ovarian cancer	2.63e-05	0.000649	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling by GPCR—IL6—ovarian cancer	2.62e-05	0.000646	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—CYTB—ovarian cancer	2.6e-05	0.000642	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—PIK3CG—ovarian cancer	2.59e-05	0.000639	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—APC—ovarian cancer	2.59e-05	0.000639	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—NRAS—ovarian cancer	2.59e-05	0.000639	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	2.57e-05	0.000633	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—CCND1—ovarian cancer	2.56e-05	0.000633	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	2.54e-05	0.000628	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—CTNNB1—ovarian cancer	2.54e-05	0.000627	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	2.49e-05	0.000615	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—MMP9—ovarian cancer	2.49e-05	0.000614	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—MAPK3—ovarian cancer	2.48e-05	0.000612	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—PTEN—ovarian cancer	2.47e-05	0.000611	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—YAP1—ovarian cancer	2.46e-05	0.000607	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling by GPCR—AKT1—ovarian cancer	2.41e-05	0.000596	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	2.38e-05	0.000588	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—YAP1—ovarian cancer	2.36e-05	0.000583	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—MAPK1—ovarian cancer	2.36e-05	0.000583	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—EGFR—ovarian cancer	2.36e-05	0.000583	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	2.34e-05	0.000577	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—CYTB—ovarian cancer	2.32e-05	0.000573	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—PIK3CD—ovarian cancer	2.28e-05	0.000562	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—PPP1CC—ovarian cancer	2.28e-05	0.000562	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—BRIP1—ovarian cancer	2.28e-05	0.000562	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	2.27e-05	0.000561	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	2.27e-05	0.00056	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR downstream signaling—PIK3CA—ovarian cancer	2.26e-05	0.000557	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—VEGFA—ovarian cancer	2.24e-05	0.000552	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—KRAS—ovarian cancer	2.23e-05	0.00055	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—STAT3—ovarian cancer	2.21e-05	0.000546	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—NRAS—ovarian cancer	2.21e-05	0.000545	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—NME2—ovarian cancer	2.17e-05	0.000535	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—CYTB—ovarian cancer	2.14e-05	0.000527	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—CYTB—ovarian cancer	2.12e-05	0.000523	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—MAPK3—ovarian cancer	2.11e-05	0.000522	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	2.07e-05	0.000511	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—MYC—ovarian cancer	2.06e-05	0.000508	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	2.06e-05	0.000507	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—PIK3CA—ovarian cancer	2.05e-05	0.000506	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—PPP1CC—ovarian cancer	2.03e-05	0.000501	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—BRIP1—ovarian cancer	2.03e-05	0.000501	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—MAPK1—ovarian cancer	2.01e-05	0.000497	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—EGFR—ovarian cancer	2.01e-05	0.000496	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—ERBB2—ovarian cancer	2.01e-05	0.000496	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—FASN—ovarian cancer	2e-05	0.000495	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—MTOR—ovarian cancer	1.99e-05	0.00049	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—PIK3CB—ovarian cancer	1.99e-05	0.00049	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—SLC5A5—ovarian cancer	1.97e-05	0.000487	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	1.94e-05	0.000479	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—FASN—ovarian cancer	1.93e-05	0.000475	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—CXCL8—ovarian cancer	1.91e-05	0.000471	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—SLC2A1—ovarian cancer	1.9e-05	0.00047	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—KRAS—ovarian cancer	1.9e-05	0.000469	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—HRAS—ovarian cancer	1.9e-05	0.000468	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—SLC5A5—ovarian cancer	1.89e-05	0.000468	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—PPP1CC—ovarian cancer	1.87e-05	0.000461	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—BRIP1—ovarian cancer	1.87e-05	0.000461	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—CDKN1B—ovarian cancer	1.86e-05	0.00046	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—BRIP1—ovarian cancer	1.85e-05	0.000457	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—PPP1CC—ovarian cancer	1.85e-05	0.000457	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR downstream signaling—AKT1—ovarian cancer	1.84e-05	0.000455	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—SLC2A1—ovarian cancer	1.83e-05	0.000452	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—CASP3—ovarian cancer	1.83e-05	0.000451	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—CYP1B1—ovarian cancer	1.83e-05	0.000451	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—IL2—ovarian cancer	1.82e-05	0.00045	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—IL6—ovarian cancer	1.81e-05	0.000448	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—CYTB—ovarian cancer	1.81e-05	0.000447	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	1.79e-05	0.000442	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—CCND1—ovarian cancer	1.78e-05	0.000439	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	1.77e-05	0.000437	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—YAP1—ovarian cancer	1.77e-05	0.000436	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—CTNNB1—ovarian cancer	1.76e-05	0.000434	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—CYP1B1—ovarian cancer	1.75e-05	0.000433	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—PIK3CA—ovarian cancer	1.75e-05	0.000431	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—MMP9—ovarian cancer	1.73e-05	0.000426	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—PTEN—ovarian cancer	1.72e-05	0.000423	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—TP53—ovarian cancer	1.69e-05	0.000417	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—AKT1—ovarian cancer	1.67e-05	0.000413	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	1.66e-05	0.000409	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—PPP2R1A—ovarian cancer	1.62e-05	0.0004	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—HRAS—ovarian cancer	1.62e-05	0.000399	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—PPP1CC—ovarian cancer	1.58e-05	0.000391	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—BRIP1—ovarian cancer	1.58e-05	0.000391	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—PPP2R1A—ovarian cancer	1.56e-05	0.000384	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—VEGFA—ovarian cancer	1.55e-05	0.000382	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	1.55e-05	0.000382	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—IL6—ovarian cancer	1.55e-05	0.000382	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—STAT3—ovarian cancer	1.53e-05	0.000379	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—NRAS—ovarian cancer	1.53e-05	0.000378	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—YAP1—ovarian cancer	1.53e-05	0.000377	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	1.51e-05	0.000373	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—ABCB1—ovarian cancer	1.5e-05	0.000371	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	1.48e-05	0.000365	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—TYMS—ovarian cancer	1.48e-05	0.000364	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—MAPK3—ovarian cancer	1.47e-05	0.000362	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—ABCB1—ovarian cancer	1.44e-05	0.000356	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—FASN—ovarian cancer	1.44e-05	0.000355	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—AKT1—ovarian cancer	1.43e-05	0.000352	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—MYC—ovarian cancer	1.43e-05	0.000352	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—TYMS—ovarian cancer	1.42e-05	0.00035	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—SLC5A5—ovarian cancer	1.42e-05	0.000349	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—CYTB—ovarian cancer	1.4e-05	0.000345	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—MAPK1—ovarian cancer	1.39e-05	0.000344	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—EGFR—ovarian cancer	1.39e-05	0.000344	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—SLC2A1—ovarian cancer	1.37e-05	0.000337	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—YAP1—ovarian cancer	1.36e-05	0.000336	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	1.35e-05	0.000333	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	1.35e-05	0.000333	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	1.33e-05	0.000328	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—KRAS—ovarian cancer	1.32e-05	0.000325	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—CYP1B1—ovarian cancer	1.31e-05	0.000324	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—YAP1—ovarian cancer	1.25e-05	0.000309	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—FASN—ovarian cancer	1.24e-05	0.000307	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—YAP1—ovarian cancer	1.24e-05	0.000307	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	1.23e-05	0.000303	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—SLC5A5—ovarian cancer	1.22e-05	0.000302	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—BRIP1—ovarian cancer	1.22e-05	0.000301	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—PPP1CC—ovarian cancer	1.22e-05	0.000301	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—PIK3CA—ovarian cancer	1.21e-05	0.000299	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—CAV1—ovarian cancer	1.19e-05	0.000294	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	1.19e-05	0.000292	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—SLC2A1—ovarian cancer	1.18e-05	0.000292	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—TP53—ovarian cancer	1.17e-05	0.000289	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—PPP2R1A—ovarian cancer	1.16e-05	0.000287	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	1.16e-05	0.000286	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	1.15e-05	0.000285	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—CAV1—ovarian cancer	1.14e-05	0.000282	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—CYP1B1—ovarian cancer	1.13e-05	0.00028	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—HRAS—ovarian cancer	1.12e-05	0.000276	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—FASN—ovarian cancer	1.11e-05	0.000274	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—SLC5A5—ovarian cancer	1.09e-05	0.00027	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	1.09e-05	0.00027	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—PIK3CG—ovarian cancer	1.08e-05	0.000267	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	1.08e-05	0.000267	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—ABCB1—ovarian cancer	1.08e-05	0.000266	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—IL6—ovarian cancer	1.07e-05	0.000264	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—YAP1—ovarian cancer	1.06e-05	0.000262	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—TYMS—ovarian cancer	1.06e-05	0.000262	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—SLC2A1—ovarian cancer	1.05e-05	0.00026	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	1.05e-05	0.000259	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—PIK3CG—ovarian cancer	1.04e-05	0.000257	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	1.03e-05	0.000255	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—FASN—ovarian cancer	1.02e-05	0.000252	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—FASN—ovarian cancer	1.01e-05	0.00025	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—CYP1B1—ovarian cancer	1.01e-05	0.00025	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—PPP2R1A—ovarian cancer	1e-05	0.000248	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—SLC5A5—ovarian cancer	1e-05	0.000248	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	1e-05	0.000247	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—SLC5A5—ovarian cancer	9.96e-06	0.000246	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—AKT1—ovarian cancer	9.89e-06	0.000244	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—SLC2A1—ovarian cancer	9.7e-06	0.000239	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—SLC2A1—ovarian cancer	9.62e-06	0.000237	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—PIK3CD—ovarian cancer	9.53e-06	0.000235	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	9.42e-06	0.000232	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—ABCB1—ovarian cancer	9.33e-06	0.00023	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—CYP1B1—ovarian cancer	9.3e-06	0.00023	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	9.23e-06	0.000228	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—CYP1B1—ovarian cancer	9.22e-06	0.000228	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—TYMS—ovarian cancer	9.16e-06	0.000226	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—PIK3CD—ovarian cancer	9.15e-06	0.000226	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—PPP2R1A—ovarian cancer	8.97e-06	0.000221	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	8.93e-06	0.00022	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—FASN—ovarian cancer	8.65e-06	0.000214	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—CAV1—ovarian cancer	8.54e-06	0.000211	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—SLC5A5—ovarian cancer	8.51e-06	0.00021	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—ABCB1—ovarian cancer	8.33e-06	0.000206	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—PIK3CB—ovarian cancer	8.3e-06	0.000205	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—PPP2R1A—ovarian cancer	8.25e-06	0.000204	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—SLC2A1—ovarian cancer	8.22e-06	0.000203	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—YAP1—ovarian cancer	8.19e-06	0.000202	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—TYMS—ovarian cancer	8.18e-06	0.000202	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—PPP2R1A—ovarian cancer	8.18e-06	0.000202	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	8.14e-06	0.000201	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	8.05e-06	0.000199	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—PIK3CB—ovarian cancer	7.98e-06	0.000197	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—CYP1B1—ovarian cancer	7.88e-06	0.000194	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—PIK3CG—ovarian cancer	7.78e-06	0.000192	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—ABCB1—ovarian cancer	7.66e-06	0.000189	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—ABCB1—ovarian cancer	7.59e-06	0.000187	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—TYMS—ovarian cancer	7.52e-06	0.000186	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—TYMS—ovarian cancer	7.46e-06	0.000184	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—CAV1—ovarian cancer	7.38e-06	0.000182	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—PTEN—ovarian cancer	7.18e-06	0.000177	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	7.05e-06	0.000174	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—PPP2R1A—ovarian cancer	6.99e-06	0.000172	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	6.95e-06	0.000172	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—PTEN—ovarian cancer	6.89e-06	0.00017	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—PIK3CD—ovarian cancer	6.84e-06	0.000169	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—PIK3CG—ovarian cancer	6.73e-06	0.000166	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—FASN—ovarian cancer	6.68e-06	0.000165	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—CAV1—ovarian cancer	6.59e-06	0.000163	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—SLC5A5—ovarian cancer	6.57e-06	0.000162	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—ABCB1—ovarian cancer	6.49e-06	0.00016	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—TYMS—ovarian cancer	6.37e-06	0.000157	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—SLC2A1—ovarian cancer	6.34e-06	0.000157	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	6.3e-06	0.000155	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—CYP1B1—ovarian cancer	6.08e-06	0.00015	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—CAV1—ovarian cancer	6.06e-06	0.00015	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—CAV1—ovarian cancer	6.01e-06	0.000148	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—PIK3CG—ovarian cancer	6e-06	0.000148	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—PIK3CB—ovarian cancer	5.96e-06	0.000147	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—PIK3CD—ovarian cancer	5.91e-06	0.000146	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	5.74e-06	0.000142	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—PIK3CG—ovarian cancer	5.52e-06	0.000136	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—PIK3CG—ovarian cancer	5.47e-06	0.000135	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—PPP2R1A—ovarian cancer	5.39e-06	0.000133	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—PIK3CD—ovarian cancer	5.28e-06	0.00013	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—PIK3CB—ovarian cancer	5.15e-06	0.000127	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—PTEN—ovarian cancer	5.15e-06	0.000127	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—CAV1—ovarian cancer	5.14e-06	0.000127	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—PIK3CA—ovarian cancer	5.06e-06	0.000125	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—ABCB1—ovarian cancer	5.01e-06	0.000124	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—TYMS—ovarian cancer	4.92e-06	0.000121	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	4.91e-06	0.000121	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—PIK3CA—ovarian cancer	4.86e-06	0.00012	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—PIK3CD—ovarian cancer	4.85e-06	0.00012	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—PIK3CD—ovarian cancer	4.81e-06	0.000119	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—PIK3CG—ovarian cancer	4.68e-06	0.000115	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—PIK3CB—ovarian cancer	4.6e-06	0.000114	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—PTEN—ovarian cancer	4.45e-06	0.00011	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—PIK3CB—ovarian cancer	4.23e-06	0.000104	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—PIK3CB—ovarian cancer	4.19e-06	0.000104	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—AKT1—ovarian cancer	4.14e-06	0.000102	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—PIK3CD—ovarian cancer	4.11e-06	0.000101	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—PTEN—ovarian cancer	3.97e-06	9.81e-05	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—AKT1—ovarian cancer	3.97e-06	9.81e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—CAV1—ovarian cancer	3.96e-06	9.78e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—PTEN—ovarian cancer	3.66e-06	9.02e-05	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—PIK3CA—ovarian cancer	3.63e-06	8.97e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—PTEN—ovarian cancer	3.62e-06	8.94e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—PIK3CG—ovarian cancer	3.61e-06	8.91e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—PIK3CB—ovarian cancer	3.58e-06	8.85e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—PIK3CD—ovarian cancer	3.17e-06	7.83e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—PIK3CA—ovarian cancer	3.14e-06	7.75e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—PTEN—ovarian cancer	3.1e-06	7.64e-05	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—AKT1—ovarian cancer	2.97e-06	7.33e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—PIK3CA—ovarian cancer	2.8e-06	6.92e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—PIK3CB—ovarian cancer	2.77e-06	6.83e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—PIK3CA—ovarian cancer	2.58e-06	6.37e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—AKT1—ovarian cancer	2.57e-06	6.33e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—PIK3CA—ovarian cancer	2.56e-06	6.31e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—PTEN—ovarian cancer	2.39e-06	5.9e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—AKT1—ovarian cancer	2.29e-06	5.65e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—PIK3CA—ovarian cancer	2.18e-06	5.39e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—AKT1—ovarian cancer	2.11e-06	5.2e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—AKT1—ovarian cancer	2.09e-06	5.16e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—AKT1—ovarian cancer	1.78e-06	4.41e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—PIK3CA—ovarian cancer	1.69e-06	4.16e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—AKT1—ovarian cancer	1.38e-06	3.4e-05	CbGpPWpGaD
